89bio, Inc.
ETNB
$9.59
$0.374.01%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -40.24M | -34.73M | -38.39M | -28.84M | -24.60M |
| Total Depreciation and Amortization | 16.00K | 10.00K | 10.00K | 14.00K | 15.00K |
| Total Amortization of Deferred Charges | 464.00K | 139.00K | 139.00K | 132.00K | 537.00K |
| Total Other Non-Cash Items | 2.03M | 2.41M | 3.13M | 3.85M | 1.64M |
| Change in Net Operating Assets | 3.43M | 1.80M | 668.00K | -5.24M | -4.68M |
| Cash from Operations | -34.29M | -30.36M | -34.45M | -30.09M | -27.10M |
| Capital Expenditure | -4.00K | -- | -- | -- | -2.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -63.64M | 38.33M | -101.81M | 4.11M | -11.06M |
| Cash from Investing | -63.64M | 38.33M | -101.81M | 4.11M | -11.06M |
| Total Debt Issued | 0.00 | 0.00 | 0.00 | 24.36M | -- |
| Total Debt Repaid | 0.00 | 0.00 | 0.00 | -21.40M | -- |
| Issuance of Common Stock | 162.17M | 117.00K | 30.77M | 319.38M | 21.19M |
| Repurchase of Common Stock | -- | -1.60M | 0.00 | -693.00K | -176.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 162.17M | -1.48M | 30.77M | 321.65M | 21.01M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 64.24M | 6.49M | -105.49M | 295.68M | -17.15M |
